A-02 · The Five

Quercetin

2
A-02
References 10–15

Quercetin

3,3′,4′,5,7-pentahydroxyflavone · the most abundant dietary flavonol · onions, capers, apples, berries
Primary: control inflammationSecondary: barrierSecondary: nourishFlavonoidBoth (preclinical)
quercetin
Red onion, capers, applesRed onion, capers, apples

Repair Guard

PERQUE · 90 tabsules · verified on Fullscript, September 2026
Form
Quercetin dihydrate 1,000 mg + pomegranate 60 mg + OPC 10 mg + magnesium 35 mg per tabsule
Additives
None.
Why this one
A full gram of quercetin with no fillers, flow agents or binders, rare in this category.
SKU
PER-131

What it is

Quercetin is the workhorse flavonoid of the plant kingdom and one of the most-studied antioxidants in existence, in cells and in animals. In people with IBD, it has almost no direct trial evidence, and I want that stated in the first paragraph rather than the last. It is in the Five because of what I have seen in practice over a decade, and because the biology is unusually well matched to what goes wrong in this disease. The evidence bar below says 2. I have left it there.

How it works

Four properties matter. Quercetin is a mast-cell stabilizer: it reduces histamine release, which is why it is the flavonoid people reach for in allergy and mast-cell conditions, and why it is relevant to the histamine-type symptoms so common in IBD. It inhibits NF-κB signaling and lowers TNF-α and IL-6 in colitis models. It is an agonist at the aryl hydrocarbon receptor (AhR), the same receptor activated by the microbiome's tryptophan metabolites, which is how it connects to the amino acid and microbiome sections of this guide; in a 2021 mouse study, quercetin's benefit in chronic colitis was AhR-dependent. And in models it raises tight-junction protein expression and increases colonic microbial diversity.

Like curcumin, it is poorly absorbed as the free aglycone, and like curcumin, that shapes which product is worth buying.

Quercetin, C15H10O7, 302.2 g/mol. A flavonol: three rings, five hydroxyl groups. Real structure; PubChem CID 5280343.
Category
Flavonoid antioxidant
Phenotype
Both, on mechanism. Observationally, dietary intake tracks with lower UC risk but not Crohn's
Other IBD
Indeterminate colitis: read both. Microscopic colitis: no trials; the mast-cell mechanism is plausible, untested.
Whole-food source
Red onion, capers, apples (skin), berries, kale, buckwheat
Cross-references
C-14 rutin (quercetin's glycoside precursor) · I-01 tryptophan (AhR pathway) · H-07 DAO (histamine)
Evidence2

No trial of supplemental quercetin in IBD as of this edition. Two 2024 prospective cohorts, one in people who already have IBD, link higher dietary quercetin intake to lower UC risk and to fewer surgeries and deaths; the scale counts dietary observation as a 2, not a 3, because it is not evidence about a supplement. Extensive animal-colitis data; randomized trials in other conditions.

Andrew's score5

Andrew's judgment, 1–5, labeled as opinion.

The evidence

Lu et al., 2024Food & Function · UK Biobank cohort, n = 187,709

Over 9.7 years, people in the highest quintile of dietary quercetin intake had 24% lower risk of developing IBD and 31% lower risk of ulcerative colitis (no association for Crohn's); parallel mouse experiments at physiological doses reproduced a protective effect. Observational: intake, not supplementation.

Wang et al., 2024J Nutr · UK Biobank cohort of people already diagnosed with IBD

Among people with IBD, those in the highest quartile of dietary quercetin intake had less than half the risk of bowel resection surgery (hazard ratio 0.46) and roughly half the all-cause mortality (0.53) of the lowest quartile. Still observational, but it is the first human signal that quercetin tracks with hard outcomes in people who have the disease.

Mechanistic review, 2022Biological activities underlying quercetin's effect in IBD

Summarizes the preclinical literature: barrier consolidation, increased colonic microbial diversity, restoration of local immune homeostasis, and reduced oxidative stress across DSS, TNBS and acetic-acid colitis models and in Citrobacter infection colitis.

AhR study, 2021Mouse chronic DSS colitis, wild-type vs AhR-knockout

Quercetin and indole-3-carbinol improved chronic colitis in normal mice; the benefit was lost in mice lacking the aryl hydrocarbon receptor, direct evidence for the AhR mechanism.

Human RCTs, other conditionsAdjacent evidence only

Randomized trials of oral quercetin exist in postmenopausal bone and inflammation (500 mg/day, 90 days), COPD (up to 2,000 mg/day, pilot), cardiac surgery inflammation, and other settings. They establish tolerability at these doses. None involved IBD.

Dose as studied

Scroll sideways to see every column →

SettingFormDoseDuration
IBD (human)No interventional trials
Postmenopausal RCTQuercetin500 mg/day90 days
COPD pilotQuercetin2,000 mg/dayshort-term

Animal doses are not translatable to people and are deliberately omitted. Not a recommendation.

What to expect

Because there are no IBD trials, there is no trial-level expectation to give you. What people describe (and what I have observed) is a reduction in histamine-type symptoms: flushing, itch, reactivity to certain foods, and the bloating that goes with them. That is observation, and it is labeled as such.

Form, timing and bioavailability

Free quercetin is absorbed poorly and variably (low single-digit percent in most studies). Absorption improves with food and fat. Phytosome preparations report substantially higher plasma levels than plain quercetin. Quercetin is very frequently co-formulated with bromelain (H-04) and vitamin C. The product above is a clean quercetin dihydrate at a full gram per tabsule, with no fillers at all, the reason it was chosen over the many quercetin products that carry three or four of the additives this guide warns against.

Who should be careful

Kidney disease (very high or intravenous quercetin has been associated with kidney injury historically); pregnancy and breastfeeding at supplemental doses; anyone with a history of hormone-sensitive conditions should discuss it, given quercetin's weak estrogenic activity in laboratory studies. Thyroid disease: in laboratory and rat studies quercetin reduced thyroid-cell growth, iodide uptake and thyroid function; there is no clinical trial of supplemental quercetin on the human thyroid, and one client of mine with a thyroid concern raised the question with me. That is one case and a laboratory signal, not a class-wide warning about polyphenols; if you have thyroid disease, put supplemental quercetin on the list you discuss with your team. (refs 201–203)

Interactions with IBD medications

Quercetin inhibits CYP3A4 and P-glycoprotein, which can raise blood levels of cyclosporine and tacrolimus; this is the interaction to take seriously. Additive antiplatelet effect with anticoagulants. May reduce absorption of some quinolone antibiotics. No known interactions with mesalamine, thiopurines, methotrexate, steroids or biologics.

Andrew's notes

This is, hands down, in my opinion, the most powerful supplement for most people with IBD. That is a strong claim, I know it is a strong claim, and I am open to being wrong about it; it is also the entry with the largest gap between the quality of the research and what I actually see. Repair Guard is the most powerful version I know, and it carries a few companion compounds. Among my clients, roughly 90% have a very positive reaction, 5% neutral, 5% negative. What I see: one to three tabsules a day as maintenance, three to five in a flare, six in a very serious flare. The bottle allows up to twelve; I think that is far too high and would not do it. This is what I observe with clients, not a dose for you; work it out with your team.

References

  1. Lu SY, Dan L, Sun S, Fu T, Chen J. Dietary quercetin intake is associated with lower ulcerative colitis risk but not Crohn's disease in a prospective cohort study and in vivo experiments. Food Funct 2024. doi:10.1039/d3fo05391a. (UK Biobank, n = 187,709.)
  2. Wang T, Lu SY, Dan L, et al. Higher dietary quercetin intake is associated with lower risk of adverse outcomes among individuals with inflammatory bowel disease in a prospective cohort study. J Nutr 2024;154(6):1861–1868.
  3. Biological activities underlying the therapeutic effect of quercetin on inflammatory bowel disease. 2022. PMC9338876.
  4. Indol-3-carbinol and quercetin ameliorate chronic DSS-induced colitis in C57BL/6 mice by AhR-mediated anti-inflammatory mechanisms. 2021. PMC7956562.
  5. Efficacy and mechanism of quercetin in the treatment of experimental colitis using network pharmacology analysis. Molecules 2023;28(1):146.
  6. ClinicalTrials.gov NCT05371340 (quercetin 500 mg/day); NCT03989271 (quercetin 2,000 mg/day). Registry entries.

READ & SHOP

Explore related supplements

Browse all 100 →

Vitamins & Minerals

Magnesium

Magnesium glycinate, the form least likely to loosen stool, 120 mg of elemental magnesium per capsule with nothing else but the capsule and a trace of ascorbyl…

Evidence 3/5Andrew 4/5

The Five

Curcumin

Curcumin is the yellow pigment of turmeric root and the most-studied plant compound in inflammatory bowel disease. It has randomized trials in ulcerative colitis, a…

Evidence 5/5Andrew 5/5

Options to explore with your care team. These are not a recommendation to take them together. Andrew earns a commission on Fullscript purchases. US shipping only.